-+ 0.00%
-+ 0.00%
-+ 0.00%

Larimar Therapeutics to host investor webcast on nomlabofusp program for Friedreich’s ataxia

PUBT·06/26/2026 20:05:27
Listen to the news
Larimar Therapeutics to host investor webcast on nomlabofusp program for Friedreich’s ataxia
  • Larimar Therapeutics will host an investor webcast on June 29, 2026, at 7:45 a.m. ET.
  • Event will cover a regulatory update on nomlabofusp for Friedreich’s ataxia.
  • Management will also discuss data from the ongoing long-term open-label study.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Larimar Therapeutics Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202606261605PRIMZONEFULLFEED9753401) on June 26, 2026, and is solely responsible for the information contained therein.